Clinical evaluation of the partition model for estimating radiation doses from yttrium-90 microspheres in the treatment of hepatic cancer

Ohto M, Ebara M, Yoshikawa M, et al. Radiation therapy and percutaneous ethanol injection for the treatment of hepatocellular carcinoma. In: Okuda K, Ishak KG, eds.Neoplasms of the liver. Tokyo Berlin Heidelberg New York: Springer; 1987: 335–341.

Sherman DM, Weichsebaum R, Order SE, Cloud L, Trey C, Piro AJ. Palliation of hepatic metastases. Cancer 1978; 41: 2013–2017.

Yoo HS, Park CH, Suh JH, et al. Radioiodinated fatty acid esters in the management of hepatocellular carcinoma: preliminary findings.Cancer Chemother Pharmacol 1989; 23 Suppl: S54-S58.

Philips R, Karnofsky DA, Hamilton LD, Nickson JJ. Roentgen therapy of hepatic metastases.Am J Radiol 1954; 71: 826–834.

Ingold JA, Reed GB, Kaplan HS, Bagshaw MA. Radiation hepatitis.Am J Roentgenol Radium Ther Nucl Med 1965; 93: 200–208.

Ariel M. Treatment of inoperable pancreatic and liver cancer by the intraarterial administration of radioactive isotopes (Y90 radiating microspheres).Ann Surg 1965; 162: 267–278.

Ariel IM, Pack GT. Treatment of inoperable cancer by intraarterial radioactive isotope and chemotherapy.Cancer 1967; 20: 793–804.

Ariel IM, Padular C. Treatment of asymptomatic cancer to the liver from primary colon and rectal cancer by intraarterial administration of chemotherapy and radioactive isotopes.J Surg Oncol 1982; 209: 151–156.

Mantravardi RVP, Spigos DG, Tan WS, Felix EL. Intraarterial yttrium-90 in the treatment of hepatic malignancy.Radiology 1982; 142: 783–786.

Blanchard RJW. Treatment of liver tumours with yttrium-90 microspheres.Can J Surg 1982; 26: 442–443.

Herba MJ, Illescas FF, Thirlwell MP, et al. Hepatic malignancies: improved treatment with intraarterial yttrium-90 microspheres.Radiology 1988; 169: 311–314.

Blanchard KJ, Morrow IM, Sutherland JB. Treatment of liver tumours with yttrium-90 microspheres alone.Can Assoc Radiol J 1989; 40: 206–210.

Houle S, Yip T, Shepherd F, et al. Hepatocellular carcinoma: pilot trial of treatment with yttrium-90 microspheres.Radiology 1989; 172: 857–860.

Shepherd FA, Rostein LE, Houle S, Yip TCK, Paul K, Sniderman KW. A phase I dose escalation trial of yttrium-90 microspheres in the treatment of primary hepatocellular carcinoma.Cancer 1992; 70: 2250–2254.

Yan ZP, Lin G, Zhao H-Y, Dong Y-H. An experimental study and clinical pilot trials of yttrium-90 microspheres through the hepatic artery for treatment of primary liver cancer.Cancer 1993; 72: 3210–3215.

Gray BN, Anderson JE, Burton MA, et al. Regression of liver metastases following treatment with yttrium-90 microspheres.Aust NZJ Surg 1992; 62: 105–110.

Lau WY, Leung TWT, Ho S, et al. Treatment of inoperable hepatocellular carcinoma with yttrium-90 microspheres. A phase I and II study.Br J Cancer 1994; 70: 994–999.

Ho S, Lau WY, Leung WT, et al. Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours.Eur J Nucl Med 1996; 23: 947–952.

Leung WT, Lau WY, Ho SKW, et al. Measurement of lung shunting in hepatocellular carcinoma with intrahepatic-arterial technetium-99m macroaggregated albumin.J Nucl Med 1994; 35: 70–73.

Lau WY, Leung TWT, Ho S, et al. Diagnostic pharmacoscintigraphy with technetium-99m macroaggregated albumin in the prediction of tumour to normal uptake ratio during therapy of inoperable hepatocellular carcinoma with yttrium-90 microspheres.Br J Radiol 1994; 67: 136–139.

Synder WS, Ford MR, Warner GG, Watson SB. “S” Absorbed dose per unit accumulated activity for selected radionuclides and organs.NM/MIRD Pamphlet No. 11. New York: Society of Nuclear Medicine; 1975.

Leung WT, Lau WY, Ho SKW, et al. Radiation pneumonitis after selective internal radiation treatment with intraarterial90yttrium-microspheres for inoperable hepatic tumours.Int J Radiat Biol Phys 1995; 33: 919–924.

Lin M. Radiation pneumonitis caused by yttrium-90 microspheres: radiologic findings.Am J Roentgenol 1994; 162: 1300–1302.

Margolis LW, Philips TL. Whole lung irradiation for metastatic tumour.Radiology 1969; 93: 1173–1178.

Fox RA, Klemp PFB, Egan G, Nina LL, Burton MA, Gray BN. Dose distribution following selective internal radiation therapy.Int J Radiat Oncol Biol Phys 1991; 21: 463–467.

Bate D, Guttman RJ. Changes in lung and pleural following two-million-volt therapy for carcinoma of the breast.Radiology 1957; 73: 372–383.

Fulkerson WJ, Mclendon RE, Prosuitz LR. Adult respiratory distress syndrome after limited thoracic radiotherapy.Cancer 1986; 57: 1941–1946.